Image credit: Wellcome Sanger Institute

Categories: Sanger Science29 January 2024

2024 Winners: Accelerator Awards for Postdocs

Postdoctoral researchers at the Wellcome Sanger Institute are at the forefront of scientific knowledge and driving world-leading research. They are also training to be the next generation of leaders in genomics and beyond, so our Postdoc Programme provides diverse opportunities for career development.

Sign up for our email update

Sign up

In 2022 we launched the Sanger Accelerator Awards for Postdocs (SAAPs), an internal funding scheme to accelerate postdocs in their career progress. SAAPs provide experience in grant applications, idea pitching and competing for independent funding. The winners also receive expert feedback from a scientific review panel, practice interview techniques and develop skills in budgeting and project management. The 2024 awards amount to £35,000, co-funded by Sanger’s portion of the UKRI Talent and Research Stabilisation Fund.

We celebrated our first two SAAPs winners in February 2023, and we are delighted to announce four new winners for 2024. Learn more about these talented researchers and their projects below.

“This year we received an exciting range of innovative applications, which is a testament to the diversity of skills, backgrounds and ideas within our postdoc community. I can’t wait to see what the winners achieve with their awards.”

Diane Swallow
Postdoc Programme Lead, Academic Programmes Team, Wellcome Sanger Institute

Dr Ana-Maria Cujba

Ana-Maria is awarded £5,000 for a research visit to Helmholtz Munich.

About the project:

Blood-borne immune cells are central to the body's immune response against viral diseases. Despite the team and collaborators analysing millions of cells from over 2,000 people, both with and without COVID-19, combining the data is challenging.

Anna-Maria will use the award to visit her collaborator, Michaela Mueller, in Helmholtz-Munich to learn advanced Artificial Intelligence (AI) techniques. She will then correlate the immune cells with disease outcomes, revealing which cells are crucial for effective immune responses and creating an ‘immune cell atlas’. This could help clinicians predict outcomes and treatments for both COVID-19 and other viral infections, and move towards personalised medicine.

“The award offers me the opportunity to learn a new skill: state-of-art machine learning approaches for large-scale single-cell data analysis. My visit to Helmholz-Munich will be my first time working outside the UK, and will help expand my research network internationally. I am very grateful for the supportive environment for postdocs at Sanger.”

Dr Ana-Maria Cujba
Teichmann group, Cellular Genetics programme, Wellcome Sanger Institute

About Ana-Maria

Ana-Maria completed an MSc in Biochemistry (with immunology) from the University of Aberdeen and spent a 1-year industrial placement at GlaxoSmithKline. Next, Anna-Maria gained an MRes in Biomedical and Translational Sciences at King’s College London (KCL), and stayed to complete a PhD in stem cell biology, diabetes, organoid research and bioinformatics.

After a short period as a Research Assistant at KCL, Ana-Maria joined the Teichmann Group at Sanger as a postdoc, co-leading two projects: age-specific COVID-19 responses in airway organoids, and cell atlasing of the human vasculature across tissues.

Now in her final year, Ana-Maria aspires to lead an independent research group to apply machine learning to single-cell analysis.

Find Ana-Maria on LinkedIn.

Dr Ellen Cameron

Ellen is granted £11,600 to research new techniques to understand molecular interactions in lichen

About the project:

Lichens are symbiotic systems of fungi and algae, which are found in diverse habitats including wood and stone.  A common UK lichen called Xanthoria parietina is well-studied, but scientists do not know how its fungi and lichen interact at the molecular level.

Current techniques are limited to predicting species interactions, so Ellen will use her award to test alternative advanced molecular methods. Ellen aims to create the first single-cell atlas for a lichen species, enhancing scientific understanding of symbiotic systems and their environmental interactions.

“The award will provide me with critical experience in new molecular techniques and data analyses, as well as research project management. I am incredibly excited to be working at the forefront of the field, with the potential to advance our understanding of the diversity of species interactions in lichen symbioses. The results could enhance the fields of microbial ecology and symbioses biology.”

Dr Ellen Cameron
Blaxter group, Tree of Life programme, Wellcome Sanger Institute

About Ellen Cameron

Ellen is an ecologist interested in applying advanced molecular techniques to characterise ecological community structures and species interactions. She is passionate about the importance of algae and the effects of environmental change.

Ellen has BSc in Biology from the University of Waterloo and an MSc in Molecular Science from Toronto Metropolitan University, both in Canada. She later returned to the University of Waterloo for a PhD in Biology, and this grew her interest in the characterisation of species interactions.

After her PhD, Ellen became an EMBL-EBI–Sanger Postdoc (ESPOD), co-supervised by Robert Finn and Nick Goldman (both EMBL-EBI) and Mark Blaxter (Sanger, Blaxter Group). Now in her final year of the ESPOD, she would like to create an independent research programme focused on terrestrial symbiotic associations.

Find Ellen on LinkedIn

Dr Karin Näsvall

Karin receives £8,000 to develop a new technique to create genome recombination maps

About the project:

Recombination, or reshuffling of genetic material, preserves genetic diversity in species and may confer survival benefits. However, scientists have a limited knowledge of the process. Existing techniques are cumbersome because they involve rearing large numbers of offspring to estimate the diversity.

With this award, Karin will develop a new method using butterfly sperm cells to create a detailed genome recombination map. If successful, this may be a fast and cost-effective way to explore recombination in organisms across the tree of life, benefitting research into biodiversity, speciation and conservation.

“As well as exploring a new method to understand the recombination process, the award will enable me to lay the foundation for my future research direction. I aim to scale up the analysis of recombination rates across whole groups of butterflies, with and without chromosomal rearrangements, to disentangle the various evolutionary forces on speciation and diversity.”

Dr Karin Näsvall
Meier group, Tree of Life programme, Wellcome Sanger Institute

About Karin Näsvall

Karin completed an MSc in Veterinary Medicine at the Swedish Agricultural University, and was a practicing veterinarian and clinic owner specialising in equine diseases for 20 years. Later, she completed an MSc in Ecology and Biodiversity at Stockholm University, followed by a PhD in Biology at Uppsala University. Moving to Sanger, Karin started her first postdoc role in the Meier Group.

Karin’s long-term goal is to become an independent researcher, working at the forefront of research into genome structure evolution. She will investigate the association between chromosomal rearrangements and recombination, as well as the macro- and micro-evolutionary consequences of these.

Find Karin on LinkedIn

Dr Sarah Buddenborg

Sarah is awarded £10,000 for her project to study parasitic worms at the single-cell level

About the project:

Parasitic worms (or helminths) infect over 1.5 billion people and countless animals worldwide, causing widespread health problems. Understanding the survival and adaptations of these worms inside their hosts may enable researchers to develop better treatments.

Sarah will use her award to make cell maps of female and male gastrointestinal (gut) worms called Haemonchus contortus, which infect sheep and goats. Her work will help reveal how these worms grow, thrive and respond to drug treatment. It will also show differences in cell types and functions between male and female worms, which may help scientists to identify new drug targets.

Find Sarah on LinkedIn

“I will begin my project shortly after returning to work from maternity leave, so it will be a challenging transition, but also something exciting to look forward to. The award will expand my skill set to new technologies that are under-utilised in helminth biology and will make my research distinctive from that of my mentor and colleagues in the same field.”

Dr Sarah Buddenborg
Doyle group, Parasites and Microbes programme, Wellcome Sanger Institute

About Sarah Buddenborg

Sarah’s research focuses on characterising the development and disease stages of parasitic worms (helminths) that infect humans and animals.

She started by undertaking a BSc in Microbiology and Molecular Genetics at Michigan State University. During her PhD in Biology at the University of New Mexico and her first Postdoc position at the Sanger Institute, she studied helminth biology using transcriptomics, genomics, and epidemiological field studies. This gave her an understanding of the devastation helminth infections cause worldwide and the knowledge and skills to use big data to answer fundamental questions about basic helminth biology.

Sarah aims to establish herself as an expert on the developmental biology of parasitic worms using cutting-edge tools to discover new avenues for intervention.

Find out more